BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 37219391)

  • 21. Safe Use of Cenobamate in Super Refractory Status Epilepticus: A Case Series.
    Carlson JM; Molyneaux BJ; Lee JW
    Neurohospitalist; 2023 Apr; 13(2):169-172. PubMed ID: 37064924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular Implications of Epilepsy: Unraveling the Elevated Risk of Mortality.
    Addanki S; Schleffer A; Kasarla R; Ely S
    Cureus; 2024 May; 16(5):e59921. PubMed ID: 38854242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Learning to detect the onset of slow activity after a generalized tonic-clonic seizure.
    Vance C; Kim Y; Zhang G; Lhatoo S; Tao S; Cui L; Li X; Jiang X
    BMC Med Inform Decis Mak; 2020 Dec; 20(Suppl 12):330. PubMed ID: 33357225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Ex Vivo Evaluation of Cenobamate Administered via Enteral Tubes.
    Ferrari L; Nisman A; Pegan A; Ursino J
    Drugs R D; 2020 Jun; 20(2):125-133. PubMed ID: 32328931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An increasing prevalence of epilepsy and stagnating or decreasing health care resources makes nationwide implementation challenging].
    Zelano J
    Lakartidningen; 2024 Apr; 121():. PubMed ID: 38591842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cross-sectional, multicenter survey of the prevalence and influencing factors for migraine in epilepsy.
    Shi W; Sun H; Peng W; Chen Z; Wang Q; Lin W; Ding M; Sun H; Wang X; Wang T; Wang X; Liu Y; Chen Y; Zhu G; Zhou D; Li J
    Epilepsia Open; 2024 May; ():. PubMed ID: 38808742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sudden cardiac arrest in a patient with epilepsy induced by chronic inflammation on the cerebral surface.
    Liu Y; Hao W; Yang X; Wang Y; Su Y
    Neural Regen Res; 2012 Feb; 7(6):470-4. PubMed ID: 25774191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term mortality of patients with West syndrome.
    Sillanpää M; Riikonen R; Saarinen MM; Schmidt D
    Epilepsia Open; 2016 Sep; 1(1-2):61-66. PubMed ID: 29588929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A global update on cenobamate based on real-world experience in over 100 000 patients.
    Ferrari L; Rosenfeld WE; Kamin M
    Epilepsia; 2024 Apr; 65(4):1149-1150. PubMed ID: 38446133
    [No Abstract]   [Full Text] [Related]  

  • 30. Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open-label study.
    Vossler DG; Rosenfeld WE; Stern S; Wade CT; Ferrari L; Kerr WT; Wechsler R
    Epilepsia; 2023 Oct; 64(10):2644-2652. PubMed ID: 37497579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
    Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
    Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of cenobamate as monotherapy compared with adjunctive therapy.
    Vashi V; Rosenfeld WE; Ferrari L; Kamin M
    Epilepsy Res; 2023 Sep; 195():107185. PubMed ID: 37429218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further advances in epilepsy.
    Fawcett J; Davis S; Manford M
    J Neurol; 2023 Nov; 270(11):5655-5670. PubMed ID: 37458794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics and SUDEP: Challenges and Future Directions.
    Whitney R; Sharma S; Jones KC; RamachandranNair R
    Seizure; 2023 Aug; 110():188-193. PubMed ID: 37413779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SUDEP: Living with the knowledge.
    Whitney R; Strohm S; Jeffs T; Jones KC; Jack SM; RamachandranNair R
    Epilepsy Res; 2023 Aug; 194():107177. PubMed ID: 37295320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature.
    Rissardo JP; Fornari Caprara AL
    Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sudden unexpected death in epilepsy during cenobamate clinical development.
    Rosenfeld WE; Ferrari L; Kerr WT; Sperling MR
    Epilepsia; 2023 Aug; 64(8):2108-2115. PubMed ID: 37219391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial.
    Krauss GL; Klein P; Brandt C; Lee SK; Milanov I; Milovanovic M; Steinhoff BJ; Kamin M
    Lancet Neurol; 2020 Jan; 19(1):38-48. PubMed ID: 31734103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on Sudden Unexpected Death in Epilepsy.
    Kløvgaard M; Sabers A; Ryvlin P
    Neurol Clin; 2022 Nov; 40(4):741-754. PubMed ID: 36270688
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.